CCL21 and neoplasm: LIGHT/TNFSF14, a lymphotoxin-related cytokine, has recently emerged for its role in the promotion of TLS-like aggregates with HEVs in vivo via the induction of CCL21 secreted by tumor endothelial cells, thus increasing the influx of T and B cells [25].